8VC

The page outlines the major functions of a modern venture capitalist and presents a framework for thinking about changes in the venture capital industry.

The page presents leadership principles shared by Aneesh Pappu and Josh Singer, inspired by the piece “A Deficit of Leadership.”

The company offers a Talent Community and lists its latest open roles.

Adrienne supports a founding partner at 8VC. Prior to joining 8VC, Adrienne supported the co-head of the Endeavor Fund at Vista Equity Partners. Adrienne graduated from the University of Texas, receiving her B.A. in finance and her M.S. in clinical therapy.

Alex Kolicich focuses on IT and Bio-IT investments. Before joining 8VC, Alex was a Partner at Formation 8 and a Principal at Mithril Capital Management, where Alex helped lead investments in AppDirect, C2FO and Helion Energy.

Alex is a member of the investment team, where he focuses on AI application layer software and robotics.

Alex Moore runs Defense for 8VC and incubates companies through 8VC’s Build Program. Prior to joining 8VC Alex was a startup operator for 12 years. Alex was the 1st employee of Palantir Technologies. Alex currently sits on boards for Palantir, Saronic, Epirus, Chaos, Gallatin, CX2, iCOMAT and Terra.

8VC partners with founders to build technologies intended to create long-term economic and societal value.

8VC is a technology and bio-sciences investment firm that invests in companies.

Arda Industries launches an AI platform that automates production line planning for factories. Users upload a product blueprint, and the software selects robots, monitors quality, and generates visual work instructions. The startup serves defense and data center electronics manufacturers, including Anduril Industries, and aims to reduce reconfiguration time from months to days. Founding team members previously led roles at OpenAI and Palantir.

Oct 2026 · SiliconANGLENews article

OpenAI acquires Orchestra Bio to integrate AI-driven agents into drug development workflows. Orchestra’s technology automates study monitoring, financial tracking, and clinical trial scheduling, addressing inefficiencies in pharmaceutical pipelines. The startup’s tools will now operate under OpenAI’s Rosalind unit, which partners with drugmakers like Novo Nordisk and Moderna to accelerate research. Orchestra Bio was founded in 2022 by CEO Ashoka Rajendra and secured $20M in seed funding from investors including Andreessen Horowitz.

Oct 2026 · SiliconANGLENews article

GitHubRepository owner

The funding comes as Ramp's annualized revenue crosses $2B, and its customer count reaches 85,000.

Oct 2026 · TechCrunchNews article